Crossveinless-2 Is a BMP Feedback Inhibitor that Binds Chordin/BMP to Regulate Xenopus Embryonic Patterning  by Ambrosio, Andrea L. et al.
Developmental Cell
ArticleCrossveinless-2 Is a BMP Feedback Inhibitor
that Binds Chordin/BMP to Regulate
Xenopus Embryonic Patterning
Andrea L. Ambrosio,1,2 Vincent F. Taelman,1,2 Hojoon X. Lee,1,2 Carrie A. Metzinger,1 Catherine Coffinier,1
and E.M. De Robertis1,*
1Howard Hughes Medical Institute, Department of Biological Chemistry, University of California, Los Angeles, Los Angeles, CA 90095, USA
2These authors contributed equally to this work
*Correspondence: ederobertis@mednet.ucla.edu
DOI 10.1016/j.devcel.2008.06.013SUMMARY
Vertebrate Crossveinless-2 (CV2) is a secreted
protein that can potentiate or antagonize BMP sig-
naling. Through embryological and biochemical
experiments we find that: (1) CV2 functions as
a BMP4 feedback inhibitor in ventral regions of the
Xenopus embryo; (2) CV2 complexes with Twisted
gastrulation and BMP4; (3) CV2 is not a substrate
for tolloid proteinases; (4) CV2 binds to purified Chor-
din protein with high affinity (KD in the 1 nM range); (5)
CV2 binds even more strongly to Chordin proteolytic
fragments resulting from Tolloid digestion or to full-
length Chordin/BMP complexes; (6) CV2 depletion
causes the Xenopus embryo to become hypersensi-
tive to the anti-BMP effects of Chordin overexpres-
sion or tolloid inhibition. We propose that the CV2/
Chordin interaction may help coordinate BMP diffu-
sion to the ventral side of the embryo, ensuring that
BMPs liberated from Chordin inhibition by tolloid
proteolysis cause peak signaling levels.
INTRODUCTION
The histotypic differentiation of ectodermal and mesodermal
cells along the dorsal-ventral (D-V) axis of the Xenopus embryo
is determined by the levels of Bone Morphogenetic Proteins
(BMPs) to which cells are exposed in the extracellular space (re-
viewed in De Robertis, 2006). High BMP levels induce differenti-
ation into epidermis or blood, while BMP inhibition causes cells
to become neural tissue or notochord. In order to develop suc-
cessfully, the embryo has to establish a robust BMP gradient
that remains stable throughout gastrulation. It was originally
thought that this gradient resulted from the simple diffusion of
BMP antagonists, such as Chordin or Noggin, secreted by a dor-
sal center called the Spemann organizer (Sasai et al., 1995; Zim-
merman et al., 1996). More recently, it has been observed that
both the dorsal and ventral regions of the embryo secrete
BMPs and anti-BMP molecules, but under opposite transcrip-
tional control (Reversade and De Robertis, 2005).
Crossveinless-2 (CV2) is one of the genes required for the for-
mation of crossveins in the Drosophila wing (Conley et al., 2000;248 Developmental Cell 15, 248–260, August 12, 2008 ª2008 ElseviBlair, 2007). Since crossvein determination requires high local
levels of BMP signals, this indicated that CV2 was involved in
the BMP pathway, presumably acting as a pro-BMP (Conley
et al., 2000). Interestingly, another crossveinless mutation,
Crossveinless-1 (cv, cv-1) affected a newmember of the Twisted
Gastrulation family, dTsg-2 (Vilmos et al., 2005; Shimmi et al.,
2005). The cloning ofDrosophilaCV2 cDNAby the Blair group re-
vealed that it was structurally related to a family of proteins such
as Chordin, Sog, and Kielin that contain CR (Cysteine-Rich, also
called vWFc domains) modules known to bind BMPs (Conley
et al., 2000). CV2 contains five CR domains and a partial vonWil-
lebrand Factor D (vWFd) domain that is involved in interactions
with cell surface proteins (Serpe et al., 2008). In vertebrates,
a mouse homolog had a similar overall structure, except for an
additional carboxy-terminal Trypsin Inhibitor-like (TIL) domain
(Coffinier et al., 2002). Although the ability of CV2 to bind
BMPs is very clear (Rentzsch et al., 2006; Zhang et al., 2007),
CV2’s effects on signaling overall can vary. On the one hand,
CV2 has been shown to function in vivo as a pro-BMP molecule
during mouse organogenesis (Ikeya et al., 2006), zebrafish gas-
trulation (Rentzsch et al., 2006), and crossvein formation in the fly
wing (Conley et al., 2000; Ralston and Blair, 2005; O’Connor
et al., 2006). On the other hand, potent inhibitory activity of
CV2 on BMPs has been described during endothelial cell differ-
entiation (Moser et al., 2003), frog embryogenesis (Coles et al.,
2004), and human osteogenic differentiation (Binnerts et al.,
2004) and in biochemical studies (Zhang et al., 2007). Thus,
CV2 displays opposing activities depending on the biological
context in which it is studied. This investigation was undertaken
to clarify the mechanistic bases for these divergent functions.
We examined CV2 activity in vivo and in vitro using embryolog-
ical and biochemical assays that lead us to conclude that the
overall function of CV2 during Xenopus D-V development is to
serve as a local BMP feedback inhibitor. When Chordin is de-
pleted, the transcriptional upregulation of CV2 lowers BMP sig-
naling levels in the ventral side of the embryo; when both CV2
and Chordin are depleted, severe ventralization of embryonic
pattern occurs. We investigated the interactions of CV2 with
other proteins involved in D-V patterning and found that CV2
forms a ternary complex with BMP4 and Tsg. Intriguingly, we
also discovered that CV2 binds to full-length Chordin protein
and even more strongly to Chordin cleavage fragments resulting
from digestion by tolloid metalloproteinases. Finally, in vivo
experiments demonstrated that when CV2 was depleted, theer Inc.
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ative tolloids (DN-Xlr) was enhanced. Thus, in addition to its role
as a feedback inhibitor, CV2 exerts pro-BMP effects via some
form of Chordin antagonism. We propose that the action of
CV2 on BMP/Chordin diffusion to the ventral side of the gastrula
explains in part the pro-BMP effects of CV2.
RESULTS
CV2 Is a BMP Feedback Inhibitor in Xenopus
InXenopus, CV2 transcripts are expressed in regionsof highBMP
signaling (such as the ventral blastopore; see Figure 1A; see
FigureS1, available online), as is thecase formouseandzebrafish
CV2 (Coffinier et al., 2002; Rentzsch et al., 2006). We generated
a morpholino oligomer against CV2 (CV2 MO) that targets the
first 25 nucleotides of the CV2 mRNA coding sequence. CV2
MO inhibited the translation of microinjected xCV2 mRNA
(Figure S4A). Its effects were specific, since the CV2 MO pheno-
type could be rescued by the coinjection of mouse CV2 mRNA
(Figures S4B and S4C), and similar phenotypes were observed
with twootherCV2MOs that targetednonoverlapping sequences
in the CV2 50 untranslated region (see the Experimental Proce-
dures). In CV2 MO-injected embryos, ventral expression of CV2
transcripts was increased (Figure 1B). Additional high-BMP
markers such as Vent-1 and Sizzledwere also increased (Figures
1D and 2B, inset, and Figure 2E), while dorsoanterior (low-BMP)
markers such as Six3, Goosecoid, and Chordin were decreased
(Figures 1E, 2G, and 2H). To determine whether the transcrip-
tional upregulation of ventral genes was caused by higher levels
of BMP4 signaling, BMP4 MO was coinjected with CV2 MO. De-
pletion ofBMP4abolished the increaseofCV2 transcripts caused
Figure 1. CV2 Is a Secreted BMP Feedback
Inhibitor
(A) Normal CV2 expression at stage 22 (hemisec-
tion). vb, ventral blastopore.
(B) CV2MO microinjection increases CV2
expression.
(C) The CV2 negative feedback loop requires
BMP4. For each experimental sample, at least 25
embryos were examined, with similar results.
(D) qRT-PCR showing increased expression of the
ventral marker Vent1 in CV2-depleted embryos.
(E) CV2 depletion reduces expression of the
dorsal/forebrain marker Six3.
(F) Endogenous Smad1 phosphorylation is in-
creased by CV2 depletion at gastrula and neurula
stages 12, 13, and 14. A pSmad1 signal was
detectable in the stage 14 uninjected lane upon
longer exposure. Total Smad1 antibody (T-
Smad1) staining was used as loading control.
byCV2depletion (Figures1A–1C). In addi-
tion, we examined the levels of phosphor-
ylation of Smad1, an effector protein
phosphorylated in response toBMPactiv-
ity. Xenopus embryos depleted of CV2
showed increased levels of Smad1 phos-
phorylation when compared to uninjected
controls incubated for the same times
(Figure 1F). Note that at three stages of gastrula and neurula,
pSmad1 levels were consistently higher in CV2 MO embryos.
We conclude from these experiments that the overall function of
CV2 in the Xenopus embryo is to serve as a BMP4 antagonist in-
ducedbyBMPsignaling. In otherwords, CV2 is a feedback inhib-
itor of BMP4 signaling.
That said, it is important to note that at later developmental
stages, CV2 morphants displayed a reduction of structures
such as the head, eyes, cement gland, endoderm, and dorsal
and ventral fins (Figures S1–S3). These phenotypes are generally
indicative of pro-BMP effects (see also Little and Mullins, 2006).
We will further address the pro-BMP effects of CV2 in Figure 6.
CV2 and Chordin Have Similar In Vivo Activities
SinceCV2andChordinaresecretedBMP4antagonistsexpressed
onopposite sides of the embryo,wenext testedwhether onegene
could ameliorate the loss of the other by depleting CV2 and Chor-
din simultaneously. Knockdown of either CV2 or Chordin alone in-
creased levels of CV2 and Szl transcripts in the ventral side (Fig-
ures 2A–2F) and inhibited the dorsal genes Goosecoid and
Chordin (Figures2Gand2H).DoubledepletionofCV2andChordin
caused an increase of these effects on D-Vmarker genes (Figures
2D–2H). The increase in BMP ventralizing signals in double CV2
and Chordin morphants was confirmed by endogenous Smad1/
5/8 phosphorylation levels at mid-gastrula (Figure 2I). These re-
sults suggest that when Chordin is depleted (Oelgeschla¨ger
etal., 2003), the transcriptional upregulationof theBMPantagonist
CV2 on the ventral side, induced by the increase in BMP signaling,
replaces the loss of Chordin, partially restoring the BMP gradient.
We conclude that the overall function of CV2 and Chordin is to
antagonize BMP signaling from opposite sides of the embryo.Developmental Cell 15, 248–260, August 12, 2008 ª2008 Elsevier Inc. 249
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Crossveinless-2 and D-V PatterningFigure 2. CV2 and Chordin Compensate for Each Other in Xenopus D-V Patterning
(A) Uninjected embryo showing CV2 expression, which is used here as a BMP4 signaling readout (n = 17). Inset shows mid-gastrula embryo stained for Chordin
(Chd) and Sizzled (Szl) (n = 24).
(B) CV2 depletion upregulates its own expression (n = 15), as well as increasing Szl and decreasing Chd (n = 20).
(C) Depletion of the BMP antagonist Chordin also increases the ventral CV2 and Szl expression domains (n = 13 and n = 18, respectively).
(D) When coinjected, CV2 MO and Chd MO show a marked expansion of the CV2 and Szl expression domains (n = 15 and n = 25, respectively).
(E–H) qRT-PCR analyses of single and double CV2 and Chd morphants for the D-V markers Szl, CV2, Gsc, and Chd at late gastrula stage 12.5.
(I) Endogenous Smad1 phosphorylation is increased by coinjection of Chd MO and CV2 MO in stage 11 embryos.
(J) The CV2 cleavage sequence contains the conserved low-pH GDPH autocatalytic site present in mucins. hMuc2, human mucin-2.
(K) Chordin, but not full-length CV2, is cleaved by the extracellular zinc-metalloproteinases Xolloid-related (Xlr) and BMP1 (lanes 1–6). However, cleavage of
full-length CV2 (80 kD band) is triggered by low pH (lanes 9 and 10).
(L–N) Ventral injections ofmRNAs encoding full-lengthCV2 (CV2-FL, n =56, ofwhich 95%hadpartial secondary axes, three independent experiments), N-terminal
CV2 fragment terminating at the GDPH cleavage site (CV2 N-Ter, n = 42, no secondary axes observed), or a secreted C-terminal fragment encoding most of the
vWFddomain (CV2C-Ter, n=45, no secondary axesobserved). The insets show injected embryosat late neurula stagehybridizedwith thepanneuralmarkerSox2.CV2 Is Not Cleaved by Tolloid
Chordin activity is controlled through proteolysis by members of
the tolloid (Tld) family (Piccolo et al., 1997). InXenopus, thesemet-
alloproteinases include Xolloid-related (Xlr) andBMP1 (Dale et al.,
2002). The analysisof secretedCV2had shown thatCV2protein is
cleaved into two fragments covalently boundby a disulfide bridge
(Binnerts et al., 2004; Kamimura et al., 2004). In zebrafish, it was
suggested that CV2 function is regulated by proteolysis and that250 Developmental Cell 15, 248–260, August 12, 2008 ª2008 Elseviethis cleavage would switch CV2 activity from an anti-BMP to
a pro-BMP molecule in the extracellular space (Rentzsch et al.,
2006). However, the CV2 cleavage site maps to the sequence
GDPH (Rentzsch et al., 2006). In the mucins, GDPH constitutes
a motif that marks posttranslational autocatalytical cleavage by
a nonenzymatic mechanism triggered by the low pH present in
the secretory pathway (Lidell et al., 2003). Interestingly, CV2 pro-
teins from all species sequenced, which include Drosophila,r Inc.
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GDPHmotif in their vWFd domain (Figure 2J and data not shown).
We compared the digestion profile of Chordin and CV2 pro-
teins by the tolloid metalloproteinases Xlr and BMP1. After 18
hr of incubation at 30C, full-length Chordin was completely di-
gested by either enzyme (Figure 2K, lanes 1–3), whereas CV2
was entirely resistant to proteolysis by Xlr or BMP1 (Figure 2K,
lanes 4–6). Purifiedmouse CV2 protein (R&D Systems) consisted
of three bands in reducing SDS gels followed by western blot us-
ing an anti-mouse CV2 antibody (Figure 2K, lane 4). The most
prominent bands corresponded to the N-terminal andC-terminal
fragments (50 and 37 kDa, respectively), and the 80 kDa upper
band corresponded to the full-length form. When purified CV2
protein was incubated in the absence of enzyme for 18 hr at
37C in buffers of pH ranging from 7.5 to 4.5, disappearance of
full-length CV2 was observed at a pH equal or lower than pH
5.5 (Figure 2K, lanes 7–10). These results strongly suggest that
CV2 is autocatalytically processed in the secretory pathway (Li-
dell et al., 2003) and is not proteolytically digested in the extra-
cellular space by tolloid proteinases.
We next reinvestigated whether the switch between the pro-
BMPandanti-BMPactivitiesofCV2couldbeexplainedbyproteo-
lytic processing. This notion was based on experiments in which
a zebrafish mRNA construct consisting only of the N-terminal
Figure 3. Twisted-Gastrulation Is Required
for the Effects of CV2 Loss of Function and
Overexpression
(A) Simultaneous depletion of CV2 and Chordin
strikingly increased CV2 expression, reflecting
increased BMP signaling (see Figure S5 for
controls).
(B) The effects of CV2 MO and Chd MO require
Twisted-Gastrulation (Tsg) activity (pro-BMP
effect of Tsg).
(C) CV2 protein injection into the blastula cavity
induces strong dorsalization of the Xenopus em-
bryo, as indicated by the expansion of the dorsal
markers Xag1, Six3, and Krox20 (n = 12, all
strongly dorsalized). Inset shows an uninjected
embryo.
(D) CV2 protein requires endogenous Tsg for its
anti-BMP activity (n = 10, all embryos similarly
affected). Inset shows Tsg MO-injected embryo.
(E) CV2 protein injection expands the neural tube
(n = 17). Inset shows uninjected embryo.
(F) Tsg and CV2 protein coinjection renders CV2
a stronger BMP antagonist, expanding the ner-
vous system marked by Sox3 (n = 16, all coin-
jected embryos were more dorsalized than those
injected with CV2 protein alone despite some indi-
vidual variations). Inset shows embryo injected
with Tsg protein alone.
CRBMP-bindingmodules revealedstrong
pro-BMP effects (Rentzsch et al., 2006).
We prepared similar constructs for Xeno-
pus CV2 terminating at the GDPH cleav-
age site, or consisting of a secreted form
of thevWFddomain (Figure2J). Ventralmi-
croinjection of full-length CV2 mRNA into
Xenopus 8-cell embryos caused secondary axis formation
(Figure 2L). However, neither the N-terminal nor the C-terminal
fragments of the extracellular domain had any phenotypic effects
(Figures 2M and 2N). Constructs of mouse (data not shown) CV2
CR domains were also devoid of activity (except for a weak anti-
BMP activity, resulting in a posteriorized anus phenotype, ob-
served for themouseCV-2N-terminal construct; data not shown).
Thus, wewere unable to confirm a role for regulated proteolysis in
switching CV2 into a pro-BMP function. In Drosophila, it has also
been recently reported that proteolytic cleavage of CV2 is not
required for its pro-BMP activity and that a fragment consisting
of theonlyCV2CRdomains is inactive (Serpeetal., 2008).Wecon-
clude thatboth theCRmodulesand thevWFddomainare required
for the BMP-modulating activity of Xenopus and mouse CV2.
Depletion of CV2 Reveals the Pro-BMP Activity of Tsg
It has been shown that Tsg can have either an anti-BMP or a pro-
BMP activity depending on the presence of Chordin (Oelgeschl-
a¨ger et al., 2000; Larraı´n et al., 2001; Little and Mullins, 2004; Xie
and Fisher, 2005). We next examined the effect of knocking
down Tsg in the context of Xenopus embryos depleted of both
CV2 and Chordin. Double morphant embryos displayed a very
large increase in BMP signaling levels reflected by upregulation
of CV2 expression (Figure 3A). However, when Tsg was alsoDevelopmental Cell 15, 248–260, August 12, 2008 ª2008 Elsevier Inc. 251
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peared (Figure 3B; see Figure S5 for a complete set of controls
for these experiments). These experiments reveal a potent pro-
BMP activity for endogenous Tsg in the absence of CV2 and
Chordin in Xenopus embryos.
Tsg Increases the Anti-BMP Activity of CV2
To show that Tsg is also important for inhibiting BMP signaling,
we examined the effects of Tsg gain of function and loss of func-
tion in embryos injected with CV2 protein into the blastocoele.
The phenotype obtained after CV2 injection (using the same pre-
dominantly cleaved protein preparation shown in Figure 2K, lane
4) was a dorsalized (low-BMP) embryo with a shortened axis,
enlarged head, and increased expression of dorsal-anterior
markers such as Six3, Xag1, Krox20, and Sox3 (Figures 3C and
3E). When CV2 protein was injected into Tsg-depleted embryos,
theyweremuch less affected and displayed almost normal levels
of dorsal marker genes (Figure 3D, compare to Figure 3C). In
overexpression experiments, coinjection of Tsg and CV2 pro-
teins showed cooperation between the two proteins, with an ex-
pansion of the panneural Sox3marker, indicating lower levels of
BMP signaling (Figure 3F). Taken together, these results indicate
that Tsg is required for CV2 protein to display its anti-BMP effect.
This finding is in some ways analogous to previous studies of
Tsg and Chordin; we therefore sought to determine whether
the underlying biochemistry is also analogous.
CV2 Forms a Ternary Complex with Tsg and BMP4
CV2 bound BMP4, and this binding was specific as it could be
competed by a 10-fold excess of BMP2, but not of TGF-b1 or
Nodal, in immunoprecipitation assays (Figure 4A and data not
shown). In addition, BMP4 signaling in L-cell fibroblasts was in-
hibited by preincubation with CV2 protein in a dose-dependent
way (Figure 4B). BMP binding and its inhibition by CV2 had
been observed previously (Moser et al., 2003; Coles et al.,
2004; Binnerts et al., 2004; Zhang et al., 2007).
We investigated Tsg/CV2 interactions by performing coimmu-
noprecipitation experiments in which anti-CV2 antibody was
bound to protein G beads. These beads were added to amixture
of CV2 and Tsg proteins, which bound to each other in solution
(Figure 4C, lane 2). We first tested whether Tsg was able to influ-
ence the binding of BMP4 to CV2 using this CV2 pull-down as-
say. Increasing amounts of BMP4 were preincubated with CV2
in the presence of a constant amount of Tsg (Figure 4D). BMP4
bound better in the presence of Tsg (Figure 4D, lanes 5–7), indi-
cating that Tsg protein facilitates the binding of BMP4 to CV2.
This was similar to what has been reported for Chordin/BMP4/DeveloTsg complexes (Oelgeschla¨ger et al., 2000; Ross et al., 2001;
Larraı´n et al., 2001).
Given the similar structure and activities of Chordin and CV2,
we asked whether a CV2-Tsg-BMP4 ternary complex was
formed. To do so, we chemically crosslinked a preincubated
mixture of CV2, Tsg, and BMP4 proteins with DSS. We identified
a complex recognized by antibodies specific for either CV2 or
BMP4, which was only formed in samples containing the three
proteins (Figure 4E). We conclude that CV2, like Chordin, forms
a ternary complex together with BMP4 and Tsg. This interaction
may help explain why Drosophila mutations in either the cv-2 or
dTsg2 (cv, cv-1) genes produce identical crossveinless pheno-
types in the fly wing (Conley et al., 2000; Shimmi et al., 2005;
Vilmos et al., 2005).
CV2 Inhibits the Binding of BMP4 to BMPR-1b
To test whether CV2 functions as an antagonist by preventing the
binding of BMP4 to its receptor, we used a soluble BMPR-1b
protein fused to an immunoglobulin constant region (BMPR-
1b-Fc). The preincubation of BMP4with CV2was able to partially
inhibit BMP4 binding to this receptor (Figure 4F, compare lanes 1
and 2), in agreement with other biochemical studies showing that
a CV2 domain blocks binding to BMPRs type I and II (Zhang
et al., 2008). The CV2 inhibitory effect was increased additively
when the same experiment was performed in the presence of
Tsg (Figure 4F, lane 4). These in vitro experiments tested only
the inhibition of binding BMP4 to BMPR-1b and do not exclude
binding of CV2 to BMP receptors such as BMPR-1a (Serpe et al.,
2008). Figure 4G shows amodel of how aCV2/Tsg/BMP4 ternary
complex could serve as a negative feedback regulator of BMP
signaling in the ventral region of the embryo.
CV2 Binds to Chordin
Mutations affecting crossvein formation in the fly wing have sug-
gested that both Sog and CV2 are required for reaching peak
BMP signaling in the presumptive territory of the crossvein (Ral-
ston and Blair, 2005; O’Connor et al., 2006; Blair, 2007). This
suggested to us that direct molecular interactions between
Chordin and CV2 might exist. Using surface plasmon resonance
(Biacore), we found that CV2 bound to Chordin protein immobi-
lized on a sensor chip (Figure 5A) or in solution in pull-down as-
says (Figure S6). Purified CV2 bound to Chordin with very high
affinity, with a KD in the low nanomolar range (1.4 ± 0.4 nM) (Fig-
ure 5A). To our surprise, pull-down assays also showed that
Chordin preincubated with BMP4 bound much better to CV2
prebound to antibody beads (Figure 5B, compare lanes 2 andFigure 4. CV2, BMP4, and Tsg Form a Ternary Complex that Inhibits BMP Signaling
(A) DSS crosslinking showing that CV2 binds BMP4 directly.
(B) CV2 dose-dependently blocks BMP4-induced phosphorylation of endogenous Smad1 in mouse L-cells; BMP4 was added for 30 min in serum-free medium
after preincubation with CV2 protein for 2 hr at 4C.
(C) Coimmunoprecipitation demonstrating that purified CV2 binds Tsg.
(D) Tsg facilitates the binding of CV2 to BMP4.
(E) CV2, BMP4, and Tsg form a ternary complex. Left panel shows DSS crosslinking products stained with anti-CV2 antibody. Right panel, same samples
examined with anti-BMP monoclonal antibody (anti-Tsg antibody showed smears due to crosslinking of Tsg with itself). Tsg protein alone is not recognized
by either antibody (not shown).
(F) CV2 and Tsg additively block the binding of BMP4 to BMPR-1b-Fc.
(G) Model of the molecular interactions of CV2, Tsg, and BMP4 in a ternary complex.pmental Cell 15, 248–260, August 12, 2008 ª2008 Elsevier Inc. 253
Developmental Cell
Crossveinless-2 and D-V PatterningFigure 5. CV2 and Chordin Bind to Each Other
(A) Biacore sensograms of the CV2-Chordin interaction in real time showing an average KD of 1.37 nM. The time at which the binding of CV2 protein stops and the
buffer wash starts is indicated.
(B) Coimmunoprecipitation in solution showing that Chordin and BMP4 bind better to CV2 in the presence of each other. Top panel shows western blot immu-
nostained with anti-Chordin, middle panel with monoclonal anti-BMP4, and bottom panel (loading control) with anti-CV2 antibody.
(C) CV2, Chordin, and BMP4 form a ternary complex. Left panel shows crosslinked products stained with BMP4monoclonal antibody; the antigenicity of BMP4 in
crosslinked complexes with Chd and CV2 increases (the unbound BMP4 dimer band indicates the amount of BMP4 protein present in the complexes). The right
panel shows the same products stained for myc-tagged Xenopus Chordin protein. The position of the BMP4/CV2/Chordin ternary complex is indicated.
(D) CV2 binds better to Chordin cleavage products than to Chordin full-length protein. Some cleavage products were present in the Chordin protein preparation,
and these were enriched in lane 2.
(E) BMP4 prebound to Chordin enhances the binding preference of CV2 beads for full-length Chordin (lane 4). At this exposure level, the binding of full-length
Chordin to CV2 is undetectable (lane 2) but is greatly increased by adding Xlr or BMP4 (lanes 3 and 4).254 Developmental Cell 15, 248–260, August 12, 2008 ª2008 Elsevier Inc.
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to CV2 in the 1 nM affinity range.
CV2 Binds with Higher Affinity to Chordin Cleaved by
Tolloid
We next investigated whether a molecular complex of CV2-
Chordin-BMP4 might be formed. To answer this question
biochemically, we preincubated the three proteins prior to cross-
linking with DSS. We were able to identify, using anti-BMP4 or
anti-Chordin antibodies, a high molecular weight complex which
formed only in the presence of the three proteins (Figure 5C,
lanes 4 and 8). This suggested that Chordin, BMP4, and CV2
can indeed form a trimolecular complex. (Attempts to identify
quaternary complexes containing also Tsg failed due to the for-
mation of high molecular weight aggregates.)
We next asked whether CV2 bound equally to full-length Chor-
din or to its proteolytic cleavage fragments.Chordin is specifically
cleaved by metalloproteinases from the tolloid family, predomi-
nantly by the ventrally expressed Xlr (Dale et al., 2002; Lee
et al., 2006). Thismechanism is crucial in D-V patterning because
it releases active BMPs fromChordin (Piccolo et al., 1997). CV2 is
expressed in the ventral side of the embryo, in a region overlap-
ping with the Xlr expression domain, but it is not itself digested
by this enzyme. Using affinity-purified Xlr enzyme (Lee et al.,
2006), we digested Xenopus Chordin for 15 min or 2 hr
(Figure 5D) and incubated the digested samples with CV2 pre-
bound to beads. Using an anti-Chordin antibody that recognizes
theChordin internal fragment (anti-I-Chordin;Piccoloet al., 1997),
it was found that the full-length protein, as well as minor cleaved
bands present in the untreated Chordin sample (which became
enriched with respect to the full-length protein during this proce-
dure), could be pulled down by the CV2 beads (Figure 5D, lanes 1
and 2, see middle panel). After digestion with Xlr, the resulting
Chordin proteolytic fragments showed a much higher affinity for
CV2; thiswasparticularly striking for theChordinmiddle fragment
lacking both CR1 and CR4 (Figure 5D, compare lanes 2 and 3 in
the middle western blot panel).
In addition, we investigated the effect of BMP4 on the affinity
of Chordin for CV2 prebound on antibody beads. The experiment
in Figure 5E shows that even at exposure levels at which the
binding of uncleaved Chordin to CV2 was so low as to be unde-
tectable, the affinity of preincubated full-length Chordin/BMP4
complex for CV2 on beads was greatly increased (Figure 5E,
compare lanes 2 and 4). This experiment also confirmed that
the affinity of Chordin binding is enhanced by Xlr digestion
(Figure 5E, compare lanes 2 and 3). We conclude from these bio-
chemical experiments that although CV2 is able to bind full-
length Chordin protein, it binds better to the Chordin cleavage
products resulting from Tolloid digestion or to full-length Chordin
complexed with BMP4.
Biological Interactions between CV2 and Chordin
We unexpectedly discovered that CV2 and Chordin had strong
interactions in vitro. In order to determine whether these bio-
chemical observations had in vivo relevance, we analyzed the
phenotypic effects of Chordin overexpression in CV2-depleted
embryos. As shown earlier (Figures 1 and 2), morpholino exper-
iments had revealed primarily anti-BMP effects for endogenous
CV2 in early Xenopus embryos. However, when CV2-depletedDeveloembryos were challenged by microinjection of 28 ng of recombi-
nant Chordin protein into the blastocoele just before gastrulation
(stage 9.5), the anti-BMP effects of Chordin were markedly in-
creased, as reflected by the expansion of the eye marker Rx2a
and the forebrain/midbrain marker, Otx2 (Figures 6A–6F). Quan-
titative RT-PCR analyses of the dorsal marker Chordin and the
ventral markers CV2 and Sizzled confirmed that the dorsalizing
effect of Chordin microinjection was enhanced by CV2 MO (Fig-
ures 6G–6I). Thus, the depletion of CV2 greatly sensitized the
embryo to the effects of exogenous Chordin protein.
We next asked whether increasing the levels of endogenous
Chordin would also reveal biological interactions between Chor-
din and CV2. Tolloid metalloproteinases play a key regulatory
role in D-V patterning, and efficient dominant-negative tolloids
are available (Lee et al., 2006). DN-Xlr mRNA (microinjected
four times around the entire embryo), which partially inhibits its
Chordin degradation, expanded the domain of expression of
the anterior and dorsal marker Otx2. However, this anti-BMP
phenotype (caused by increased stability of endogenous Chor-
din) was enhanced in embryos depleted of CV2 (Figures 6J–
6L). As shown earlier, the depletion of CV2 alone causes partially
ventralized phenotypes (Figures 1 and 2B) which reflect an over-
all anti-BMP function for CV2, and these anti-BMP effects were
greatly potentiated in double CV2/Chd morphants (Figure 2D).
Thus, while low levels of Chordin and CV2 cooperate with one
another as BMP antagonists, CV2 can also dampen the activity
of excess Chordin. This latter activity may also be relevant to
some of the pro-BMP effects observed in Figures S1–S3.
The most remarkable aspect of the Chordin or DN-Xlr overex-
pression results is that the overall effect of endogenous CV2 on
signaling is switched from negative (anti-BMP) to positive (anti-
Chordin, pro-BMP) when Chordin levels are increased. These
in vivo experiments show that the effects of the ventral protein
CV2 are dependent on the levels of the dorsal protein Chordin
and that CV2 can be either anti-BMP or pro-BMP. The hypersen-
sitivity of CV2 morphants to Chordin indicates that one of the
functions of CV2 is to dampen the effects of Chordin. This might
be achieved, for example, by facilitating the removal and degra-
dation of full-length Chordin, its proteolytic fragments, or Chor-
din/BMP complexes after any or all of these factors bind to
CV2 on the cell membranes of the ventral side of the wild-type
embryo. Since CV2 is poorly diffusible (Rentzsch et al., 2006;
Serpe et al., 2008), this anti-Chordin activity may act in combina-
tion with tolloid proteinases to concentrate BMPs for peak sig-
naling ventrally (Figure 7).
DISCUSSION
The function of CV2 presents an intriguing scientific mystery, be-
cause it has been found both to increase (Conley et al., 2000;
Rentzsch et al., 2006; Ikeya et al., 2006; Kamimura et al., 2004;
Coles et al., 2004) or to antagonize (Moser et al., 2003; Coles
et al., 2004; Binnerts et al., 2004; Zhang et al., 2007) BMP signal-
ing according to the experimental setting. In this study, we have
used a combination of biochemical and Xenopus embryological
assays in an attempt to unravel this puzzle. We found that CV2/
Tsg/BMP complexes act as BMP inhibitors locally and that the
pro-BMP function of CV2 may result in part from its ability to
bind Chordin and Chordin/BMP complexes originating frompmental Cell 15, 248–260, August 12, 2008 ª2008 Elsevier Inc. 255
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Crossveinless-2 and D-V PatterningFigure 6. The Pro-BMP Function of CV2 Is Revealed in Epistatic Experiments with Chordin or Tolloid
(A) Expression of the eye field marker Rx2a in uninjected Xenopus late neurula embryo (n = 45), anterior view.
(B) Chordin protein injection (2 mM, 60 nl) into the blastocoele at late blastula (stage 9.5) caused dorsalization and an increase in Rx2a expression (n = 54).
(C) CV2-depleted hosts were more sensitive to the anti-BMP effects of Chordin, as indicated by the expansion in the Rx2a domain (n = 48).256 Developmental Cell 15, 248–260, August 12, 2008 ª2008 Elsevier Inc.
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Crossveinless-2 and D-V PatterningFigure 7. Model of the Molecular Interac-
tion of CV2, Chordin, Tsg, and BMP4
(A) Model of the regulation of D-V patterning by
a network of extracellular proteins secreted by
the dorsal and ventral centers of the Xenopus
gastrula. Arrows in black indicate direct protein-
protein interactions in the extracellular space,
blue arrows transcriptional regulation by the
BMP-responsive transcription factors Smad1/5/
8, and the red arrow the hypothetical flux of Chor-
din/ADMP/BMP from the dorsal toward the ventral
center of the embryo, where it would bind to CV2.
This model of D-V patterning is self-regulating be-
cause at low BMP levels the transcription of the
BMP-like molecule ADMP is activated, and at
high BMP levels the BMP antagonist CV2 and
the tolloid inhibitor Sizzled are upregulated (Rever-
sade and De Robertis, 2005; Lee et al., 2006). The
function of Tsg is to both increase BMP inhibition
by CV2 and Chd and to promote BMP4 signaling
in their absence. The tolloid protease Xlr cleaves
Chordin/ADMP/BMP complexes, releasing active
BMPs concentrated on the ventral side.
(B) Model in which Chordin flow would help
transport BMPs and Chordin from the dorsal to
the ventral side of the Xenopus embryo. Three
possible outcomes are indicated.more dorsal locations. In the presence of tolloids, CV2 would
serve to concentrate BMP signals ventrally.
CV2 Is a BMP4 Feedback Inhibitor
When CV2 was depleted in the Xenopus embryo, the early phe-
notype observed was one of increased BMP signaling, indicating
that a main function of CV2 is to serve as a BMP4 feedback in-
hibitor (Figure 1). Our results in Xenopus contrast with a previous
report in zebrafish that reached a different conclusion (Rentzsch
et al., 2006). The finding that CV2 protein functions as an overall
anti-BMP molecule in Xenopus is strongly supported by the fact
that CV2 and Chordin MOs cooperate with each other to ventral-
ize the embryo (Figure 2). At later stages of development, zebra-
fish anti-CV2 MO showed loss of the ventral fin (Rentzsch et al.,
2006; Moser et al., 2007) and, in agreement with this, we ob-
served a similar phenotype in Xenopus. The development of
the ventral fin is thought to reflect the pro-BMP activity of Chor-
din, which is transported together with BMP toward the ventral
side (Little and Mullins, 2006). Thus, our data may suggest that
the pro-BMP effects of CV2 are mediated by an analogous flux
of Chordin/BMP to the ventral side of the embryo.
CV2 Concentrates Chordin/BMP
The principal biochemical finding reported here is that CV2 binds
full-length Chordin with high affinity. In Figure 7, we present a re-
vised model for Xenopus D-V patterning based on our biochem-Develoical and phenotypic results and on current thinking on how the
crossveins are formed inDrosophila (O’Connor et al., 2006; Blair,
2007). We propose that the pro-BMP effects of CV2 are caused
in part by its action on Chordin/Tsg/BMP complexes diffusing to
sites of highCV2 expression in the ventral side of the embryo. On
the dorsal side of the Xenopus embryo, Chordin would predom-
inantly bind ADMP (Anti-Dorsalizing Morphogenetic Protein),
a BMP-like molecule that plays an important role in the self-reg-
ulation of D-V pattern (Figure 7; Reversade and De Robertis,
2005). Tsg binds to both CV2 and Chordin, making them better
BMP antagonists, as well as to BMP4 (facilitating BMP4 signal-
ing in the absence of CV2 and Chordin) (Figure 7A). CV2 would
provide localized binding sites for Chordin/BMP, regulating the
shape of the D-V patterning gradient. CV2 does not diffuse far
from its site of synthesis, due to a strongmembrane/extracellular
matrix heparin sulfate proteoglycan (HSPG) binding site in its
vWFd domain (Rentzsch et al., 2006). In Drosophila, CV2 binds
to theGPImembrane-tethered HSPGDally and is not able to sig-
nal beyond one or two cell diameters in wing clones (Serpe et al.,
2008). CV2 undergoes autocatalytic cleavage (Lidell et al., 2003)
and is resistant to degradation by tolloids (Figure 2). However,
Chordin and Chordin/BMP complexes are readily cleaved by
ventrally expressed Xlr. Thus, binding of Chordin to CV2 would
concentrate Chordin and its BMP complexes at the ventral
center of the Xenopus embryo (Figure 7A, flux indicated by red
arrow).(D) Uninjected early neurula (stage 13, side view) showing Otx2 expression in the future forebrain and midbrain regions (n = 19).
(E) Chordin protein injection expands Otx2 in wild-type embryos (n = 25).
(F) CV2 depletion sensitizes the embryo to the effects of Chordin on Otx2 (n = 23). Note that the border of Otx2 expression expands posteriorly.
(G–I) qRT-PCR analysis of the D-V markers Chd, CV2, and Szl after Chordin protein injection into wild-type and CV2-depleted embryos at late blastula. The bars
indicate standard deviation between two groups of seven embryos each.
(J andK) Anterior viewsof uninjected control or embryomicroinjected four timeswith 250pgofDN-XlrmRNA,which inhibits the proteolytic degradation ofChordin.
Note that theOtx2-positive forebrain (fb), midbrain, and cement gland (cg) regions are expanded, consistent with the anti-BMP effects of Tolloid inhibition (n = 27).
(L) In CV2-depleted embryos, Otx2 expression is greatly expanded by DN-Xlr mRNA (n = 27). The dotted line indicates the eye field (eye), which is more weakly
stained by Otx2.pmental Cell 15, 248–260, August 12, 2008 ª2008 Elsevier Inc. 257
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alternative fates. First, in the absence of tolloids they would be
inactivated and removed by CV2 binding. In this respect, it is in-
teresting to note that the binding of BMP/Chordin to CV2 is of
higher affinity than that of full-length Chordin alone, so this
anti-BMP effect could be very efficient. Second, in the presence
of tolloid, complexes of Chordin with BMPs (perhaps prebound
to CV2, see Figure 7B) would be cleaved, releasing active
BMPs that would bind to BMPRs to achieve peak BMP signaling
ventrally (Piccolo et al., 1997; Reversade and De Robertis, 2005).
CV2 has a high affinity for the proteolytic fragments of Chordin
digestion, and this could further facilitate BMP signaling by re-
taining spent Chordin fragments and releasing BMP.
This model of extracellular protein-protein interactions is sup-
ported by the phenotypic effects of CV2 depletion in Xenopus. In
wild-type embryos, endogenous CV2 had an overall anti-BMP
function. However, CV2-depleted embryos became hypersensi-
tive to the dorsalizing effects of injected Chordin protein or
DN-Xlr mRNA (Figure 6). This suggests that CV2 inhibits excess
Chordin in the embryo. Remarkably, Chordin overexpression or
Xlr inhibition reversed the net effect of CV2 knockdown, reveal-
ing a pro-BMP activity for endogenous CV2. This anti-Chordin
activity should remain localized to the ventral side of the embryo
since CV2 is not diffusible (Rentzsch et al., 2006; Serpe et al.,
2008). By removing Chordin ventrally, CV2 could facilitate BMP
signaling. In addition, any BMP/Chordin complexes reaching
the ventral side can also signal, provided Xlr proteolytic activity
is available. In conclusion, both embryological and biochemical
experiments suggest that interactions betweenCV2 andChordin
play a key role in Xenopus D-V patterning.
It should at this point be noted that while overexpressed Chor-
din clearly diffuses long-range in Xenopus, and endogenous Sog
has been shown to diffuse along the entireDrosophila embryonic
D-V axis (O’Connor et al., 2006), the range of action for endoge-
nous Xenopus Chordin protein remains the subject of active in-
quiry. If Chordin normally exerts its anti-BMP effects over a rela-
tively short range, the functional Chordin gradient observed
in vivo may arise from a ‘‘summation’’ of proteins secreted
from different tissues, downstream of distinct transcriptional
controls (Blitz et al., 2000). Recently, diffusion of microinjected
BMP4 from the dorsal to the ventral side of the Xenopus gastrula
has been directly visualized and shown to require endogenous
Chordin (Ben-Zvi et al., 2008). Regardless of the origin of the rel-
evant Chordin protein, our data demonstrate that CV2 coordi-
nates both anti-BMP and pro-BMP Chordin functions on the
ventral side of the embryo.
Comparison between Xenopus and Drosophila CV2
The proposed role of CV2 as a regulator of the flux of Chordin/
BMP complexes (Figure 7) may explain only part of its pro-BMP
effects. A recent study in Drosophila has shown that CV2 binds
specifically to the BMP type I receptor Thickveins (Tkv), sug-
gesting that CV2 may promote BMP signaling by facilitating
transfer to BMPR (Serpe et al., 2008). We have been able to
confirm this binding for vertebrate proteins, using commercial
BMPR-1a (ALK-3) and CV2 mouse proteins (unpublished
data). A mathematical model was proposed to explain how
high levels of CV2 would inhibit BMP signaling and lower levels
could enhance signaling (Serpe et al., 2008). Our finding that258 Developmental Cell 15, 248–260, August 12, 2008 ª2008 ElseviChordin/BMP complexes bind avidly to CV2 complements
this model. In the Drosophila wing, Sog/Tsg2/Dpp complexes
diffuse long-range from the longitudinal veins to the crossveins,
where Dpp is released by Tolloid-related (Ralston and Blair,
2005; Blair, 2007). The crossveins are sites of peak BMP signal-
ing. CV2 protein remains tethered to its site of synthesis in
crossveins (Serpe et al., 2008) and could serve to concentrate
diffusible Sog/Tsg2/Dpp complexes. An interesting possibility
is that the cleavage of Chordin or Sog by tolloids might take
place on Chordin/Tsg/BMP already bound to CV2 (Figure 7B).
Since we have observed that mouse CV2 associates with
BMPR-1a in vitro, this interaction might also facilitate BMPR
signaling in vertebrates. The Chordin digestion products, which
have an even higher affinity for CV2 than full-length Chordin
(Figure 5D), would remain attached to CV2 and be removed,
perhaps by endocytosis. This extracellular machinery would
ensure that peak BMP signaling is achieved in the ventral
center.
In conclusion, the finding that CV2 binds to Chordin will help
develop mechanistic models for the diverse CV2 activities de-
scribed in the literature. The important discovery by Serpe et al.
(2008) that CV2 also binds to Tkv greatly increases the regulatory
possibilities of this system. The biochemical pathway involving
Chordin, BMP, Tsg, Tolloid, and CV2 proteins has revealed
a new paradigm for the exquisite extracellular regulation of
embryonic cell differentiation. This pathway is ancestral to D-V
patterning of all bilateral animals, since the entire system has
been conserved during evolution (De Robertis, 2008).
EXPERIMENTAL PROCEDURES
Morpholino Oligomers, mRNA, and Protein Injections
Morpholino antisense oligomers (MO) were obtained from Gene Tools. The
CV2 MO used in most of this study had the sequence 50-TGCCAGTGG
AGAAGCAGCTGTGCAT-30. CV2 MO1 and CV2 MO2, used as additional
specificity controls, target the CV2 mRNA 50UTR and had the sequences
50-TATAGCATCCAGACTGTTGCAGGTT-30 and 50-TTAGAGTGAGGAGTCAA
GAACAGAG-30, respectively. Other MOs were as described: Chordin MO
(Oelgeschla¨ger et al., 2003), Tsg MO (Blitz et al., 2003), and BMP4MO (Rever-
sade and De Robertis, 2005). Each MO was microinjected (500 mM or 250 mM,
4 nl) four times radially into 2- or 4-cell embryos. For mRNA injections, a full-
length Xenopus CV2 EST clone (#XL039c09) was used as a template for
PCR. 50 and 30 untranslated regions were deleted, and a Flag-tagged signal
peptide (Piccolo et al., 1997) was added and cloned into pCS2 to generate
FL-CV2, Nter-CV2, and Cter-CV2. Synthetic mRNAs were prepared by linear-
izing with NotI, transcribed with SP6 polymerase, and 500 pg injected. The
three mRNAs produced Flag-tagged proteins of the expected size in microin-
jected embryos (data not shown). Recombinant mouse CV2 or Tsg proteins
(R&D Systems) were microinjected (5 mM, 40 nl) into the blastocoele at late
blastula stage (stage 9.5). The most effective dose of Chordin protein for injec-
tions was 60 nl at 2 mM. Procedures for whole-mount in situ hybridization are
available at http://www.hhmi.ucla.edu/derobertis/index.html.
Biochemical Methods
Recombinant mouse CV2, mouse Tsg, mouse Chordin, and human BMP4
were purchased from R&D Systems, and Xenopus Chordin-Myc was
produced in baculovirus (Piccolo et al., 1996). Phospho-Smad1 was detected
in whole embryos using anti-phospho-Smad1/Smad5/Smad8 antibody
(1:1000, Cell Signaling Technology) and anti-total Smad1 (1:1000, Zymed) as
loading control. Protein extracts were made from at least ten embryos for
each sample. For in vitro digestions, 30 nM Chordin-Myc or 50 nM recombi-
nant mouse CV2 was incubated in Xld buffer (Piccolo et al., 1997) with 2 nM
affinity-purified Xlr-Flag (Lee et al., 2006) or with 293T cells xBMP1-transfecteder Inc.
Developmental Cell
Crossveinless-2 and D-V Patterningconditioned medium at 25C for 18 hr. Goat anti-mouse CV2 antibody (R&D
Systems) was diluted 1:2000 for western blots.
For in vitro autocatalytic cleavage, 50 nM recombinant mouse CV2 was in-
cubated at 37C in citric acid-Na2HPO4 (McIlvaine buffer) at varying pH for 18
hr. For crosslinking, the indicated proteins were incubated in PBS for at least 1
hr at room temperature. Disuccinimidyl suberate (DSS, Pierce) was added to
a final concentration of 1 mM and incubated with agitation for 45 min at
room temperature, and the reaction was stopped by adding Tris-HCl (pH 8)
to a final concentration of 50 mM. Samples were directly separated on SDS
gels under reducing conditions. For coimmunoprecipitation, the indicated pro-
teins were incubated overnight at 4C in TS buffer (20 mM Tris [pH 7.5], 150
mM NaCl, 1.5 mM CaCl2, and 1.5 mM MgCl2).
Anti-mouse CV2 antibody (R&D Systems) was bound to protein G agarose
(Pierce) and 20 ml of beads added to each reaction. In some cases, CV2 was
prebound to CV2 antibody beads and washed prior to incubation with the
other proteins. For the binding of Chordin fragments to CV2, 25 nM Chordin-
Myc was incubated with 2 nM purified Xlr-PC (Lee et al., 2006) for 15 min or
2 hr at 25C. Metalloproteinase reactions were stopped by addition of 1 mM
of the zinc chelator 1-10 orthophenanthroline on ice. All biochemical experi-
ments were repeated at least two times.
For BMP receptor binding assays, recombinant mouse CV2, mouse Tsg,
and human BMP4 were preincubated at room temperature for 1 hr, and
BMPR IB-Fc protein (R&D Systems) was added for an additional hour. BMP
bound to the BMPR was detected by anti-BMP4 western blot after protein A
precipitation of the receptor (Larraı´n et al., 2001).
For quantitative RT-PCR (qRT-PCR), total RNA was extracted from pools of
five embryos with Absolute RNA MicroPrep Kit, reverse transcribed, and ana-
lyzed in a MX3000P apparatus using Brilliant SYBR GREEN QPCRMaster Mix
(Stratagene).
Surface Plasmon Resonance Analyses
Surface Plasmon Resonance (SPR) measurements were performed on a Bia-
core 3000 system. Recombinant Chordin was dissolved at 10 mg/ml in 10 mM
sodium acetate (pH 5.0) and immobilized on a CM5 (carboxy methylcellulose)
sensor chip using the amine couplingmethod to a level of about 2500 response
units. Binding and washes were performed in PBS using recombinant mouse
CV2 protein dissolved in the same buffer. Each experimental cycle consisted
of a flow of commercial CV2 at indicated concentrations followed by washes
with buffer alone. After each cycle, chip surfaces were regenerated by
removing noncrosslinked proteins with 10 mM HCl. Data were analyzed with
BIAevaluation 4.1 software, and curve-fitting was done with the assumption
of one-to-one binding (Wang et al., 2003).
SUPPLEMENTAL DATA
Supplemental Data include six figures and can be found with this article online
at http://www.developmentalcell.com/cgi/content/full/15/2/248/DC1/.
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